BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 25960214)

  • 1. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel biphenyl urea derivate inhibits the invasion of breast cancer through the modulation of CXCR4.
    Zhan Y; Zhang H; Li J; Zhang Y; Zhang J; He L
    J Cell Mol Med; 2015 Jul; 19(7):1614-23. PubMed ID: 25753200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways.
    Song ZY; Wang F; Cui SX; Qu XJ
    Cancer Invest; 2018 Jan; 36(1):10-18. PubMed ID: 29381400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells.
    Shen B; Zheng MQ; Lu JW; Jiang Q; Wang TH; Huang XE
    Asian Pac J Cancer Prev; 2013; 14(9):5403-8. PubMed ID: 24175834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
    Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L
    Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
    Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin signaling induces the transcription of cystathionine-γ-lyase, a stimulator of tumor in colon cancer.
    Fan K; Li N; Qi J; Yin P; Zhao C; Wang L; Li Z; Zha X
    Cell Signal; 2014 Dec; 26(12):2801-8. PubMed ID: 25193114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SDF-1/CXCR4 promotes F5M2 osteosarcoma cell migration by activating the Wnt/β-catenin signaling pathway.
    Lu Y; Hu B; Guan GF; Chen J; Wang CQ; Ma Q; Wen YH; Qiu XC; Zhang XP; Zhou Y
    Med Oncol; 2015 Jul; 32(7):194. PubMed ID: 26026718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
    Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
    Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor.
    Yadav VR; Sung B; Prasad S; Kannappan R; Cho SG; Liu M; Chaturvedi MM; Aggarwal BB
    J Mol Med (Berl); 2010 Dec; 88(12):1243-53. PubMed ID: 20798912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of CD44 inhibits proliferation, migration, and invasiveness in hepatocellular carcinoma cells by modulating CXCR4/Wnt/β-Catenin Axis.
    Song X; Ding F; Luo W; Tao J; Yang K; Li Q; Zhang Z
    Acta Biochim Pol; 2023 Feb; 70(1):117-122. PubMed ID: 36735564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
    Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML
    Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.
    Li JK; Yu L; Shen Y; Zhou LS; Wang YC; Zhang JH
    World J Gastroenterol; 2008 Apr; 14(15):2308-13. PubMed ID: 18416455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer.
    Zhang S; Qi L; Li M; Zhang D; Xu S; Wang N; Sun B
    J Exp Clin Cancer Res; 2008 Nov; 27(1):62. PubMed ID: 18983683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
    Jiang YP; Wu XH; Xing HY; DU XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4.
    Manu KA; Shanmugam MK; Rajendran P; Li F; Ramachandran L; Hay HS; Kannaiyan R; Swamy SN; Vali S; Kapoor S; Ramesh B; Bist P; Koay ES; Lim LH; Ahn KS; Kumar AP; Sethi G
    Mol Cancer; 2011 Sep; 10():107. PubMed ID: 21880153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of CDK-8 inhibits colon cancer hepatic metastasis by regulating Wnt/β-catenin pathway.
    Cai WS; Shen F; Feng Z; Chen JW; Liu QC; Li EM; Xu B; Cao J
    Biomed Pharmacother; 2015 Aug; 74():153-7. PubMed ID: 26349978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.